Expression of Melan-A/MART-1 antigen as a prognostic factor in primary cutaneous melanoma

Détails

ID Serval
serval:BIB_E31F8AB643B9
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Expression of Melan-A/MART-1 antigen as a prognostic factor in primary cutaneous melanoma
Périodique
International Journal of Cancer
Auteur(s)
Berset  M., Cerottini  J. P., Guggisberg  D., Romero  P., Burri  F., Rimoldi  D., Panizzon  R. G.
ISSN
0020-7136 (Print)
Statut éditorial
Publié
Date de publication
01/2001
Volume
95
Numéro
1
Pages
73-7
Notes
Journal Article --- Old month value: Jan 20
Résumé
In this study we assessed the expression of the Melan-A/MART-1 antigen by immunohistochemistry using monoclonal antibody A103 in 73 primary cutaneous melanomas and its correlation with tumor staging and patient survival. Melan-A/MART-1 was expressed in 90% of primary tumors, with loss of expression increasing with Breslow thickness. Kaplan-Meier analysis demonstrated a significantly reduced disease-free interval and overall survival rate for patients not expressing this antigen. The poor prognosis of such patients was even worse for those presenting with a primary melanoma and a Breslow thickness of > or = 1 mm. Thus, Melan-A/MART-1 is not only a useful and specific additional marker for the diagnosis of primary cutaneous melanoma, but it may also help refine the prognosis of patients with malignant melanoma.
Mots-clé
Antigens, Neoplasm Disease Progression Disease-Free Survival Female Humans Immunohistochemistry Male Melanoma/*diagnosis/*metabolism Multivariate Analysis Neoplasm Proteins/*biosynthesis Prognosis Skin Neoplasms/*diagnosis/*metabolism Time Factors
Pubmed
Web of science
Création de la notice
28/01/2008 11:28
Dernière modification de la notice
20/08/2019 16:06
Données d'usage